Opdualag™
Opdualag™ (nivolumab and relatlimab-rmbw) is a medicine that may treat a type of skin cancer called melanoma by working with your immune system
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Bristol Myers Squibb |
CLASS: LAG-3 inhibitor |
PRESCRIBED BY: Oncologists |
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Every four weeks |
Length of infusion: 30 mins |
FOR MORE INFORMATION: |